Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-004562
Filing Date
2023-03-08
Accepted
2023-03-08 21:32:12
Documents
2
Period of Report
2023-03-06

Document Format Files

Seq Description Document Type Size
1 form4-03092023_020304.html 4  
1 form4-03092023_020304.xml 4 5589
2 ex24-03092023_020305.htm EX-24 7702
  Complete submission text file 0001415889-23-004562.txt   14622
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FUSION PHARMACEUTICALS, INC. 270 LONGWOOD ROAD SOUTH HAMILTON D0 L8P OA6
Business Address
Lee Philina (Reporting) CIK: 0001845080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 23717994